LianBio IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| LianBio | LIAN - NASDAQ |
$15.00-$17.00 | $16.00 | $15.50 | 20.3 million ADSs | 11/1/2021 |
| Goldman Sachs, Jefferies, BofA Securities | ||||||
Co-Manager(s): Raymond James | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-10-01 Terms Added 2021-10-20 | ||||||
LianBio Quote & Chart - Click for current quote - LIAN
IPO Boutique aggregates information on public companies and private companies, such as "LIAN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About LianBio (adapted from LianBio prospectus):
They are a global, science-driven biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a global, science-driven biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LIAN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.